• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine carboxylic acids and derivatives Pyrrolidine carboxylic acids

Introduction to Pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 953079-94-2)

Pyrrolidine-3-carboxylic acid hydrochloride, identified by the Chemical Abstracts Service (CAS) number 953079-94-2, is a significant compound in the realm of pharmaceutical and biochemical research. This compound, featuring a pyrrolidine core structure with a carboxylic acid functional group at the third position and its hydrochloride salt form, has garnered attention due to its versatile applications in drug discovery and molecular chemistry.

The pyrrolidine scaffold is a common motif in natural products and bioactive molecules, contributing to its prevalence in medicinal chemistry. The introduction of a carboxylic acid group at the third position enhances the compound's reactivity, making it a valuable intermediate in synthetic pathways. Furthermore, the hydrochloride salt form improves its solubility and stability, facilitating its use in various biochemical assays and pharmaceutical formulations.

In recent years, Pyrrolidine-3-carboxylic acid hydrochloride has been extensively studied for its potential role in developing novel therapeutic agents. Its structural features make it a promising candidate for modulating biological pathways associated with neurological disorders, inflammation, and metabolic diseases. The compound's ability to interact with specific enzymes and receptors has been explored in preclinical studies, highlighting its significance in drug design.

One of the most intriguing aspects of Pyrrolidine-3-carboxylic acid hydrochloride is its utility as a building block in the synthesis of more complex molecules. Researchers have leveraged its reactive sites to create derivatives with enhanced pharmacological properties. For instance, modifications at the carboxylic acid group have led to the development of novel inhibitors targeting enzymes involved in cancer progression. Similarly, alterations at the nitrogen atom of the pyrrolidine ring have resulted in compounds with improved binding affinities to therapeutic targets.

The hydrochloride salt form of Pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 953079-94-2) offers additional advantages in pharmaceutical applications. Its crystalline structure ensures consistent purity and quality, which is crucial for clinical trials and commercial drug production. Moreover, its solubility profile allows for easy formulation into injectable solutions, oral tablets, and other dosage forms, making it adaptable to diverse therapeutic needs.

Recent advancements in computational chemistry have further enhanced the understanding of Pyrrolidine-3-carboxylic acid hydrochloride's interactions with biological systems. Molecular docking studies have revealed its potential as an antagonist for certain ion channels and as a modulator of G-protein coupled receptors (GPCRs). These findings have opened new avenues for developing treatments against conditions such as epilepsy, hypertension, and neurodegenerative diseases.

In addition to its pharmacological applications, Pyrrolidine-3-carboxylic acid hydrochloride has found utility in biochemical research. Its role as a substrate or inhibitor in enzymatic reactions has been investigated to elucidate metabolic pathways and enzyme mechanisms. This has implications for understanding disease pathogenesis and developing targeted therapies.

The synthesis of Pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 953079-94-2) involves multi-step organic reactions that highlight the compound's synthetic versatility. Techniques such as reductive amination, carboxylation reactions, and salt formation are commonly employed to construct the pyrrolidine core and introduce functional groups. The optimization of these synthetic routes ensures high yields and purity, which are essential for downstream applications.

The safety profile of Pyrrolidine-3-carboxylic acid hydrochloride has been evaluated through various toxicological studies. Preliminary findings suggest that it exhibits low toxicity at therapeutic concentrations, making it a promising candidate for further clinical development. However, comprehensive safety assessments are necessary to ensure its suitability for human use.

Future research directions for Pyrrolidine-3-carboxylic acid hydrochloride include exploring its potential in combination therapies and investigating its long-term effects. The integration of this compound into novel drug candidates could revolutionize treatments for several diseases by targeting multiple biological pathways simultaneously.

In conclusion, Pyrrolidine-3-carboxylic acid hydrochloride (CAS No. 953079-94-2) is a multifaceted compound with significant implications in pharmaceutical research and drug development. Its structural features, reactivity, and potential therapeutic applications make it a valuable asset in the quest for innovative treatments across various medical fields.

• 72580-53-1((3S)-pyrrolidine-3-carboxylic acid)
• 72580-54-2((R)-Pyrrolidine-3-carboxylic acid)
• 159694-26-5(Pyrrolidine-3,4-dicarboxylicacid)
• 68464-02-8((3r)-3-pyrrolidinecarboxylic Acid)
• 885952-85-2(4-Methylpyrrolidine-3-carboxylic acid)
• 1202245-51-9((3R)-pyrrolidine-3-carboxylic acid;hydrochloride)
• 1351343-41-3(4,4-Dimethylpyrrolidine-3-carboxylic acid hydrochloride)
• 59378-87-9(Pyrrolidine-3-carboxylic acid)
• 412320-71-9(4-(Hydroxymethyl)pyrrolidine-3-carboxylic acid)
• 1124369-40-9((3S)-pyrrolidine-3-carboxylic acid hydrochloride)